| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.18B | 38.48B | 36.38B | 35.55B | 33.87B | 31.32B |
| Gross Profit | 9.19B | 8.88B | 8.49B | 8.47B | 8.18B | 7.41B |
| EBITDA | 5.00B | 4.78B | 4.58B | 4.44B | 4.32B | 3.62B |
| Net Income | 3.38B | 3.21B | 3.05B | 2.92B | 2.79B | 2.28B |
Balance Sheet | ||||||
| Total Assets | 49.98B | 52.02B | 50.81B | 48.17B | 46.82B | 44.31B |
| Cash, Cash Equivalents and Short-Term Investments | 23.71B | 24.30B | 27.13B | 24.04B | 24.20B | 21.53B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 6.72B | 8.54B | 8.95B | 8.39B | 8.70B | 8.12B |
| Stockholders Equity | 43.26B | 43.47B | 41.86B | 39.78B | 38.12B | 36.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.40B | 4.59B | 2.91B | 2.77B | 2.13B |
| Operating Cash Flow | 0.00 | 1.57B | 4.71B | 2.95B | 2.93B | 2.24B |
| Investing Cash Flow | 0.00 | -3.09B | -1.14B | -1.34B | -57.84M | 342.11M |
| Financing Cash Flow | 0.00 | -1.61B | -983.76M | -1.26B | -703.42M | -983.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥66.33B | 17.51 | ― | 1.39% | 13.38% | 24.62% | |
77 Outperform | €84.73B | 20.34 | 31.13% | 2.17% | 16.12% | 46.57% | |
76 Outperform | €57.84B | 16.90 | 7.99% | 3.03% | 8.26% | 9.09% | |
74 Outperform | ¥51.86B | 11.25 | ― | 3.16% | 4.47% | 11.37% | |
72 Outperform | ¥52.85B | 20.35 | ― | 1.64% | 13.48% | 35.63% | |
63 Neutral | ¥64.41B | 84.69 | ― | 0.62% | 18.86% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |